René Figueredo

1.6k total citations
33 papers, 669 citations indexed

About

René Figueredo is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, René Figueredo has authored 33 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in René Figueredo's work include Radiopharmaceutical Chemistry and Applications (5 papers), DNA Repair Mechanisms (5 papers) and Neuroblastoma Research and Treatments (4 papers). René Figueredo is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (5 papers), DNA Repair Mechanisms (5 papers) and Neuroblastoma Research and Treatments (4 papers). René Figueredo collaborates with scholars based in Canada, Cuba and United States. René Figueredo's co-authors include James Koropatnick, Rolando Pérez, Peter J. Ferguson, Saman Maleki Vareki, Normando Iznaga-Escobar, Olga Torres, Mayra Ramos, Tania Crombet, Mark Vincent and Agustín Lage and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

René Figueredo

31 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
René Figueredo Canada	14	321	261	161	114	100	33	669
Xiaojing Yang China	14	167 0.5×	209 0.8×	145 0.9×	89 0.8×	61 0.6×	55	594
Elena Tsanou Greece	17	246 0.8×	360 1.4×	76 0.5×	154 1.4×	79 0.8×	26	802
Eric C. Yang Canada	8	132 0.4×	182 0.7×	51 0.3×	50 0.4×	92 0.9×	14	411
Céline Clémenson France	15	299 0.9×	238 0.9×	93 0.6×	78 0.7×	186 1.9×	24	613
Helen B. Forrester Australia	16	159 0.5×	282 1.1×	203 1.3×	277 2.4×	47 0.5×	28	637
Whoon Jong Kil United States	10	137 0.4×	149 0.6×	134 0.8×	63 0.6×	25 0.3×	28	430
Saskia E. Rademakers Netherlands	9	127 0.4×	299 1.1×	154 1.0×	129 1.1×	42 0.4×	12	691
Luca Ventura Italy	16	239 0.7×	378 1.4×	142 0.9×	28 0.2×	52 0.5×	59	735
Fraser L. Baker United States	12	217 0.7×	307 1.2×	119 0.7×	166 1.5×	37 0.4×	29	709
Robert L. Hong United States	10	61 0.2×	195 0.7×	173 1.1×	38 0.3×	44 0.4×	12	481

Countries citing papers authored by René Figueredo

Since Specialization

Citations

This map shows the geographic impact of René Figueredo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by René Figueredo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites René Figueredo more than expected).

Fields of papers citing papers by René Figueredo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by René Figueredo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by René Figueredo. The network helps show where René Figueredo may publish in the future.

Co-authorship network of co-authors of René Figueredo

This figure shows the co-authorship network connecting the top 25 collaborators of René Figueredo. A scholar is included among the top collaborators of René Figueredo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with René Figueredo. René Figueredo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fernandes, Ricardo, Kelly J. Baines, Eric Winquist, et al.. (2026). Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trial. Nature Medicine.

Figueredo, René, et al.. (2023). IL-12 and IL-27 Promote CD39 Expression on CD8+ T Cells and Differentially Regulate the CD39+CD8+ T Cell Phenotype. The Journal of Immunology. 210(10). 1598–1606. 13 indexed citations

Krishnamoorthy, Mithunah, et al.. (2022). Inducing mismatch repair deficiency sensitizes immune-cold neuroblastoma to anti-CTLA4 and generates broad anti-tumor immune memory. Molecular Therapy. 31(2). 535–551. 4 indexed citations

Ninkov, Marina, Crystal L. Schmerk, Seema Nair Parvathy, et al.. (2022). Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinoma. Cancer Immunology Immunotherapy. 72(5). 1247–1260. 16 indexed citations

Figueredo, René, Meng Zhang, Peter J. Ferguson, et al.. (2020). CD5 blockade enhances ex vivo CD8 ⁺ T cell activation and tumour cell cytotoxicity. European Journal of Immunology. 50(5). 695–704. 28 indexed citations

Ferguson, Peter J., et al.. (2015). Synergistic Cytotoxicity against Human Tumor Cell Lines by Oncolytic Adenovirus dl1520 (ONYX-015) and Melphalan. Tumori Journal. 102(1). 31–39. 6 indexed citations

Vareki, Saman Maleki, Di Chen, Peter J. Ferguson, et al.. (2015). IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells. PLoS ONE. 10(11). e0143435–e0143435. 34 indexed citations

Figueredo, René, et al.. (2015). siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine. Oncotarget. 6(26). 22397–22409. 7 indexed citations

Leong, Hon S., Saman Maleki Vareki, René Figueredo, et al.. (2014). BRCA2 inhibition enhances cisplatin‐mediated alterations in tumor cell proliferation, metabolism, and metastasis. Molecular Oncology. 8(8). 1429–1440. 30 indexed citations

10.

Vareki, Saman Maleki, René Figueredo, Di Chen, et al.. (2014). Abstract 3765: Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, γ radiation, and cisplatin. Cancer Research. 74(19_Supplement). 3765–3765. 1 indexed citations

11.

Ferguson, Peter J., et al.. (2013). Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined “Complementary Lethality”. Molecular Therapy — Nucleic Acids. 2. e78–e78. 15 indexed citations

12.

Vareki, Saman Maleki, Peter J. Ferguson, René Figueredo, et al.. (2013). Abstract C77: A novel BRCA2 targeting antisense oligonucleotide sensitizes human tumor cells to chemotherapy and radiotherapy - the induction of ‘complementary lethality’ by targeting DNA repair.. Molecular Cancer Therapeutics. 12(11_Supplement). C77–C77. 1 indexed citations

13.

Figueredo, René, Y Bureau, James Koropatnick, et al.. (2013). Imaging Tumor Growth Non-invasively Using Expression of MagA or Modified Ferritin Subunits to Augment Intracellular Contrast for Repetitive MRI. Molecular Imaging and Biology. 16(1). 63–73. 18 indexed citations

14.

Ferguson, Peter J., et al.. (2012). 192 Enhancement of Cisplatin Cytotoxicity by Antisense Oligonucleotides Targeting DNA Repair Protein BRCA2: Creation of Synthetic Lethality to Improve Selectivity. European Journal of Cancer. 48. 58–58. 1 indexed citations

15.

Goldhawk, Donna E., Claude Lemaire, Cheryl R. McCreary, et al.. (2009). Magnetic Resonance Imaging of Cells Overexpressing MagA, an Endogenous Contrast Agent for Live Cell Imaging. Molecular Imaging. 8(3). 129–39. 52 indexed citations

16.

Figueredo, René, et al.. (2008). ODN 491, a Novel Antisense Oligodeoxynucleotide That Targets Thymidylate Synthase, Exerts Cell-Specific Effects in Human Tumor Cell Lines. DNA and Cell Biology. 27(5). 229–240. 4 indexed citations

17.

Figueredo, René, et al.. (2005). Local and systemic toxicity of h-R3, an anti-epidermal growth factor receptor monoclonal antibody, labeled with 188osmiun after the intracerebral administration in rats. Experimental and Toxicologic Pathology. 56(4-5). 313–319. 4 indexed citations

18.

Tejuca, Mayra, Isabel Dı́az, René Figueredo, et al.. (2004). Construction of an immunotoxin with the pore forming protein StI and ior C5, a monoclonal antibody against a colon cancer cell line. International Immunopharmacology. 4(6). 731–744. 36 indexed citations

19.

Mishra, Anil K., Normando Iznaga-Escobar, René Figueredo, et al.. (2002). Preparation and comparative evaluation of 99mTc-labeled2-iminothiolane modified antibodies and CITC-DTPA immunoconjugatesof anti-EGF-receptor antibodies. Methods and Findings in Experimental and Clinical Pharmacology. 24(10). 653–653. 13 indexed citations

20.

Crombet, Tania, Olga Torres, Vanina Rodríguez, et al.. (2001). Phase I Clinical Evaluation of a Neutralizing Monoclonal Antibody Against Epidermal Growth Factor Receptor in Advanced Brain Tumor Patients: Preliminary Study. Hybridoma. 20(2). 131–136. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact